Rezultati - Sven de Vos

Refine Results
  1. 1
    Comparative analysis of genes regulated by PML/RARα and PLZF/RARα in response to retinoic acid using oligonucleotide arrays

    Comparative analysis of genes regulated by PML/RARα and PLZF/RARα in response to retinoic acid using oligonucleotide arrays od Dorothy J. Park, Peter T. Vuong, Sven de Vos, Dan Douer, H. Phillip Koeffler

    Izdano 2003
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow

    Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow od Wolf‐K. Hofmann, Sven de Vos, Martina Komor, Dieter Hoelzer, William Wachsman, H. Phillip Koeffler

    Izdano 2002
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women

    Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women od Said Jw, Taizo Tasaka, Seisho Takeuchi, Hiroya Asou, Sven de Vos, Ethel Cesarman, DM Knowles, HP Koeffler

    Izdano 1996
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation

    Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation od Wolf‐K. Hofmann, Letetia C. Jones, Nathan A. Lemp, Sven de Vos, Harald Gschaidmeier, Dieter Hoelzer, Oliver G. Ottmann, H. Phillip Koeffler

    Izdano 2002
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death

    Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death od Mary C. Clark, Mabel Pang, Daniel K. Hsu, Fu‐Tong Liu, Sven de Vos, Randy D. Gascoyne, Jonathan W. Said, Linda G. Baum

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Safety and efficacy of navitoclax, a BCL-2 and BCL-X <sub>L</sub> inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study

    Safety and efficacy of navitoclax, a BCL-2 and BCL-X <sub>L</sub> inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study od Sven de Vos, John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod Humerickhouse, John Hayslip, John C. Pesko, Wyndham H. Wilson

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells

    Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells od Walid Bin Mohd Said, K. Chien, Seisho Takeuchi, Taizo Tasaka, Hiroya Asou, Steve K. Cho, Sven de Vos, Ethel Cesarman, DM Knowles, HP Koeffler

    Izdano 1996
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas

    Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas od Sven de Vos, Wolf-Karsten Hofmann, Thomas M. Grogan, Utz Krug, Mathew Schrage, Thomas P. Miller, Jonathan Braun, William Wachsman, H. Phillip Koeffler, Jonathan W. Said

    Izdano 2003
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

    Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correl... od Eric D. Hsi, Sin‐Ho Jung, Raymond Lai, Jeffrey L. Johnson, James R. Cook, Dan Jones, Sven deVos, Bruce D. Cheson, Lloyd E. Damon, Jonathan W. Said

    Izdano 2008
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma

    Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lympho... od Patrick B. Johnston, Amanda F. Cashen, Petros Nikolinakos, Anne Beaven, Stefan K. Barta, Gajanan Bhat, Steven J. Hasal, Sven de Vos, Yasuhiro Oki, Changchun Deng, Francine M. Foss

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Management of adverse events associated with idelalisib treatment: expert panel opinion

    Management of adverse events associated with idelalisib treatment: expert panel opinion od Steven Coutré, Jacqueline C. Barrientos, Jennifer R. Brown, Sven de Vos, Richard R. Furman, Michael J. Keating, Daniel Li, Susan O’Brien, John M. Pagel, Martin Poleski, Jeff P. Sharman, Nai-Shun Yao, Andrew D. Zelenetz

    Izdano 2015
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells

    Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells od Carsten Müller‐Tidow, Björn Steffen, Thomas Cauvet, Lara Tickenbrock, Ping Ji, Sven Diederichs, Bülent Sargin, Gabriele Köhler, Matthias Stelljes, Elena Puccetti, Martin Ruthardt, Sven deVos, Scott W. Hiebert, H. Phillip Koeffler, Wolfgang E. Berdel, Hubert Serve

    Izdano 2004
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

    A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors od Sven de Vos, Andres Forero‐Torres, Stephen M. Ansell, Brad S. Kahl, Bruce D. Cheson, Nancy L. Bartlett, Richard R. Furman, Jane N. Winter, Henry G. Kaplan, John M. Timmerman, Nancy Whiting, Jonathan G. Drachman, Ranjana H. Advani

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

    Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study od André Goy, Steven H. Bernstein, Brad S. Kahl, Benjamin Djulbegović, Michael J. Robertson, Sven de Vos, Elliot Epner, A. Krishnan, John P. Leonard, Sagar Lonial, Sunita D. Nasta, Owen A. O’Connor, Hongliang Shi, Anthony Boral, Richard I. Fisher

    Izdano 2008
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma od Richard I. Fisher, Steven H. Bernstein, Brad S. Kahl, Benjamin Djulbegović, Michael J. Robertson, Sven de Vos, Elliot Epner, Amrita Krishnan, John P. Leonard, Sagar Lonial, Edward A. Stadtmauer, Owen A. O’Connor, Hongliang Shi, Anthony Boral, André Goy

    Izdano 2006
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    The landscape of new drugs in lymphoma

    The landscape of new drugs in lymphoma od Anas Younes, Stephen M. Ansell, Nathan Fowler, Wyndham H. Wilson, Sven de Vos, John F. Seymour, Ranjana H. Advani, Andres Forero, Franck Morschhauser, Marie José Kersten, Kensei Tobinai, Pier Luigi Zinzani, Emanuele Zucca, Jeremy S. Abramson, Julie M. Vose

    Izdano 2016
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Multicenter Randomized Phase II Study of Weekly or Twice-Weekly Bortezomib Plus Rituximab in Patients With Relapsed or Refractory Follicular or Marginal-Zone B-Cell Lymphoma

    Multicenter Randomized Phase II Study of Weekly or Twice-Weekly Bortezomib Plus Rituximab in Patients With Relapsed or Refractory Follicular or Marginal-Zone B-Cell Lymphoma od Sven de Vos, André Goy, Shaker R. Dakhil, Mansoor N. Saleh, Peter McLaughlin, Robert J. Belt, Christopher R. Flowers, Mark Knapp, Lowell L. Hart, Dipti Patel‐Donnelly, Martha Glenn, Stephanie A. Gregory, Charles Holladay, Tracy Zhang, Anthony Boral

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma

    Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymp... od Andres Forero‐Torres, Sven de Vos, Brad Pohlman, Maksim Pashkevich, Damien M. Cronier, Nam H. Dang, Susan P. Carpenter, Barrett W. Allan, James G. Nelson, Christopher A. Slapak, Mitchell R. Smith, Brian K. Link, James E. Wooldridge, Kristen N. Ganjoo

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma

    Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma od Ariela Noy, Sven de Vos, Catherine Thiéblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Graham P. Collins, Shuo Ma, Morton Coleman, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Alina Smith, Brian Munneke, Isaiah W. Dimery, Darrin M. Beaupre, Robert Chen

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

    Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial od Sattva S. Neelapu, Michael Dickinson, Javier Muñoz, Matthew L. Ulrickson, Catherine Thiéblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Peter A. Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C. Chávez

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: